Evaluating risk assessment tools for managing blood clots in heart surgery patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the effectiveness of the Modified Caprini Risk Assessment Score combined with D-Dimer levels in predicting and managing lower extremity venous thrombosis (LEVT) among patients undergoing cardiothoracic surgery in Baghdad. Participants will undergo risk assessments and D-Dimer testing during their hospital stay, with subsequent monitoring for LEVT incidence and related complications. The study seeks to determine if the combined use of these tools enhances predictive accuracy compared to using them separately.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Inpatients with a hospital stay over 3 days
* Written informed consent obtained from patients or their legal guardians.
* Availability for postoperative follow-up to assess outcomes like LEVT development or related complications.

Exclusion Criteria:

* Preexisting LEVT or Pulmonary Embolism: Diagnosed before the index surgery.
* Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease).
* receiving any anticoagulation therapy for any reason.
* patients who did not undergo a postoperative D-dimer test.
* Incomplete Data: missing essential clinical or laboratory data for Modified Caprini Score calculation or D-Dimer measurement.
* Pregnancy: pregnant women or those within six weeks postpartum.
* Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols.

Where it's running

• College of Medicine - Al-Nahrain University
  Baghdad, Iraq Recruiting

Study contacts

• Study coordinator: Abdul-Ilah R. Khamis
• Email: allaabed987@ced.nahrainuniv.edu.iq
• Phone: +9647838571013

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Iliac vein stenting with dedicated venous stents for chronic post-thrombotic venous ulcers

  This study tests whether using dedicated iliac venous stents to reopen obstructed veins helps heal chronic leg ulcers caused by post-thrombotic syndrome in adults.

  Recruiting Ain Shams University · Cairo · NCT07762222

• Wearable ultrasound sensors for early diagnosis and real-time monitoring

  This project will try a wearable ultrasound sensor to detect and monitor blood clots, heart-failure changes, and continuous bedside issues in ICU patients.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07009873

• Padua Score to predict VTE risk in thoracic surgery patients

  This study tests whether the Padua Prediction Score can better predict VTE risk in people undergoing thoracic surgery.

  Recruiting Al-Nahrain University · Baghdad, Kadhimiya · NCT06732726

• Thrombectomy system to treat leg DVT

  This trial tests a peripheral thrombectomy device to treat lower extremity deep vein thrombosis in adults.

  Recruiting BrosMed Medical Co., Ltd · Shanghai · NCT07749820

• Impedance-based Sensing During DVT Care

  Researchers are testing a non-invasive IPG device to help detect and monitor deep vein thrombosis in people undergoing catheter-directed thrombolysis, by comparing it to standard imaging methods.

  Recruiting Tampere University · Tampere and 1 other locations · NCT07665320

• Predicting blood clots after lung cancer surgery

  This project will try to use clinical, surgical, and lab data to predict which adults having lung cancer surgery may develop blood clots after the operation.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT07439991

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.